Skip to content

Evaluation of the Use of Metal Stents as Part of the Treatment of Benign Biliary Strictures

Prospective Evaluation of the Clinical Utility of Placement of Metal Stent for Benign Biliary Strictures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01238900
Enrollment
23
Registered
2010-11-11
Start date
2009-05-31
Completion date
2015-05-31
Last updated
2015-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Biliary Strictures

Brief summary

The purpose of this study is to study the evaluation of the use of metal stents as part of the treatment of benign biliary strictures.

Detailed description

In patients with benign biliary strictures, the use of fully covered self-expandable metal stents (SEMS) has been proposed as an alternative to plastic stenting, but high quality prospective data is sparse. This study was performed to evaluate the long -term effectiveness and safety of a new fully covered SEMS for benign biliary strictures.

Interventions

PROCEDUREEndoscopic Retrograde Cholangiopancreatography (ERCP)

Endoscopic Retrograde Cholangiopancreatography (ERCP) with placement of metal stent in the bile duct

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject is 18 years or older 2. Subject has benign biliary stricture 3. Subject must be able to give informed consent

Exclusion criteria

1. Any contraindication to Endoscopic Retrograde Cholangiopancreatography (ERCP) 2. The subject is unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Short Term Success Rate in the Resolution of Biliary Strictures6 monthsShort-term success was defined as resolution of the stricture as documented by rapid drainage of contrast out of the proximal biliary tree and easy passage of stone extraction balloon inflated to the size of the proximal bile duct. If the biliary stricture had resolved at the 6-month follow-up ERCP, patients were classified as short-term success. If stricture was not resolved at 6-month ERCP then a new SEMS was placed; if the stricture had resolved at the time of the second stent removal, the patient was also classified as short-term success.
Long-term Success Rate in Resolution of Biliary Stricturesat least 12 months after stent removalLong-term success was defined as no clinical evidence of recurrence of the biliary stricture during the follow-up period as documented by laboratory findings or imaging and no further need for further endoscopic or surgical interventions.

Secondary

MeasureTime frameDescription
Number of Endoscopic Treatments Per PatientAt time of procedureThe average number of ERCPs performed per patient required for resolution of benign strictures.
Ease of Stent Removalat time of procedureThe ease of stent removal was graded on a 4-point scale (with ease, mild difficulty, significant difficulty, and failed).
Frequency and Severity of Adverse Events (Including Stent Migration)up to 12 monthsAdverse events were defined and graded using the 2010 American Society for Gastrointestinal Endoscopy consensus criteria

Countries

United States

Participant flow

Participants by arm

ArmCount
Benign Biliary Strictures
Participants underwent Endoscopic Retrograde Cholangiopancreatography (ERCP) with placement of self-expandable metal stents (SEMS) in the bile duct.
23
Total23

Withdrawals & dropouts

PeriodReasonFG000
<12 Months Post Stent RemovalLost to Follow-up4
<12 Months Post Stent Removalpersistent stricture after stenting1

Baseline characteristics

CharacteristicBenign Biliary Strictures
Age, Customized60 years
number of participants with history of prior stenting
number with no history of stenting
10 participants
number of participants with history of prior stenting
number with prior stenting
13 participants
Region of Enrollment
United States
23 participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
10 Participants
Stricture etiology
Chronic pancreatitis (CP)
14 participants
Stricture etiology
Gallstone related
1 participants
Stricture etiology
Idiopathic
4 participants
Stricture etiology
Orthotopic liver transplantation (OLT)
4 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
9 / 23
serious
Total, serious adverse events
0 / 23

Outcome results

Primary

Long-term Success Rate in Resolution of Biliary Strictures

Long-term success was defined as no clinical evidence of recurrence of the biliary stricture during the follow-up period as documented by laboratory findings or imaging and no further need for further endoscopic or surgical interventions.

Time frame: at least 12 months after stent removal

Population: Per-protocol analysis, the 18 participants available for long term success follow-up consisted of: 11 with CP, 3 with OLT, and 4 others. Intention to treat analysis of long-term success consisted of 22 overall patients, 12 CP patients, 3 OLT patients, and 7 other patients. This analysis included all patients lost to follow-up as long-term failures.

ArmMeasureGroupValue (NUMBER)
Benign Biliary StricturesLong-term Success Rate in Resolution of Biliary StricturesOverall15 participants
Benign Biliary StricturesLong-term Success Rate in Resolution of Biliary StricturesChronic pancreatitis (CP)8 participants
Benign Biliary StricturesLong-term Success Rate in Resolution of Biliary StricturesOrthotopic liver transplantation (OLT)3 participants
Benign Biliary StricturesLong-term Success Rate in Resolution of Biliary StricturesAll others4 participants
Primary

Short Term Success Rate in the Resolution of Biliary Strictures

Short-term success was defined as resolution of the stricture as documented by rapid drainage of contrast out of the proximal biliary tree and easy passage of stone extraction balloon inflated to the size of the proximal bile duct. If the biliary stricture had resolved at the 6-month follow-up ERCP, patients were classified as short-term success. If stricture was not resolved at 6-month ERCP then a new SEMS was placed; if the stricture had resolved at the time of the second stent removal, the patient was also classified as short-term success.

Time frame: 6 months

Population: Of the 23 participants that entered the study, 22 saw short-term success. The population consisted of 14 Chronic pancreatitis patients, 4 postorthotopic liver transplant patients, and 5 others.

ArmMeasureGroupValue (NUMBER)
Benign Biliary StricturesShort Term Success Rate in the Resolution of Biliary StricturesOverall22 participants
Benign Biliary StricturesShort Term Success Rate in the Resolution of Biliary StricturesChronic pancreatitis (CP)14 participants
Benign Biliary StricturesShort Term Success Rate in the Resolution of Biliary StricturesOrthotopic liver transplantation (OLT)3 participants
Benign Biliary StricturesShort Term Success Rate in the Resolution of Biliary StricturesAll others5 participants
Secondary

Ease of Stent Removal

The ease of stent removal was graded on a 4-point scale (with ease, mild difficulty, significant difficulty, and failed).

Time frame: at time of procedure

ArmMeasureGroupValue (NUMBER)
Benign Biliary StricturesEase of Stent RemovalWith ease21 participants
Benign Biliary StricturesEase of Stent RemovalMild difficulty0 participants
Benign Biliary StricturesEase of Stent RemovalSignificant difficulty2 participants
Benign Biliary StricturesEase of Stent RemovalFailed0 participants
Secondary

Frequency and Severity of Adverse Events (Including Stent Migration)

Adverse events were defined and graded using the 2010 American Society for Gastrointestinal Endoscopy consensus criteria

Time frame: up to 12 months

Population: Stent migration was seen in 9/23 patients (5 downstream, 4 upstream). It was without clinical complications except in one case. Post-procedure pain experienced by 1 patient was effectively treated by downgrading the stent size to a smaller diameter.

ArmMeasureGroupValue (NUMBER)
Benign Biliary StricturesFrequency and Severity of Adverse Events (Including Stent Migration)Downstream Stent Migration5 participants
Benign Biliary StricturesFrequency and Severity of Adverse Events (Including Stent Migration)Postprocedure pain due to expansion force of SEMS1 participants
Benign Biliary StricturesFrequency and Severity of Adverse Events (Including Stent Migration)Complications during stent placement0 participants
Benign Biliary StricturesFrequency and Severity of Adverse Events (Including Stent Migration)Complications during stent removal0 participants
Benign Biliary StricturesFrequency and Severity of Adverse Events (Including Stent Migration)upstream stent migration4 participants
Secondary

Number of Endoscopic Treatments Per Patient

The average number of ERCPs performed per patient required for resolution of benign strictures.

Time frame: At time of procedure

ArmMeasureValue (MEAN)
Benign Biliary StricturesNumber of Endoscopic Treatments Per Patient2.4 endoscopic treatments

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026